Friday, November 30, 2018

Melinta - Are We Getting the Message?

›
Along with  Achaogen , Melinta has now  announced  a corporate restructuring where they will amputate virtually all of their R&D effo...
1 comment:
Monday, November 12, 2018

Antibiotic Awareness Week - Talk vs. Action?

›
This is antibiotic awareness week. To mark this week, there has been a great deal of talk and the publication of several important papers a...
4 comments:
Wednesday, October 24, 2018

The UK and Antibiotic Resistance - What Happened?

›
  In 2016 I wrote a series of blogs on the many ways the United Kingdom was leading the fight against antibiotic resistance.    Tamar Gho...
1 comment:
Tuesday, October 2, 2018

Musings on the Introduction of New Antibacterials to the Marketplace

›
I know its been a few weeks since my last blog. A great deal of discussion around antibiotic development and pull incentives is still occ...
Thursday, September 13, 2018

Pathogen Specific Antibacterial Development - Webinar Summary

›
On Tuesday, GARDP sponsored a live webinar on the development of antibacterial drugs for specific pathogens highlighting drugs targeting ...
Tuesday, September 4, 2018

Webinar - Development of Pathogen-Specific Antibacterials

›
I am writing to invite you to our webinar on September 11, 2018. These webinars are part of a series – Clinical Development of Antibacter...
Thursday, August 16, 2018

Investors Hate Antibiotics - With Good Reason!

›
Back in the mid-1990s and even beyond the tech crash of the early 2000s, an antibiotic biotech could frequently raise $50-100 million in ...